top of page

Based on the information you submitted

You have
Stage IIC
Melanoma

Introduction:

Patients with stage IIc disease has  T4b disease (i.e., Breslow thickness greater than 4.0mm and with ulceration).

Survivor Outcome:

According to the 2018 AJCC data, for patients with stage IIC disease, the 5-year and 10-year melanoma-specific survival probability are 82% and 75%.

Treatment:
Adopted from NC
CN Guideline 2022

For this group, the treatment involves excision of the tumor along with a standard surgical margin of 2 cm.

Sentinel lymph node biopsy (SLNB) is discussed and offered.

Routine imaging (e.g., X-ray or CT scan) or lab tests are not recommended.

In certain cases, your physicians, specifically the medical oncologists may discuss the role of adjuvant treatment. 

INTERVIEW WITH THE EXPERTS

youtube-icon-flat-red-play-button-logo-vector.png

01

Dr. Thomas Wang explains the sentinel lymph node biopsy (SLNB) procedure

youtube-icon-flat-red-play-button-logo-vector.png

02

Dr. Thomas Wang describes explains the sentinel lymph node biopsy procedure

youtube-icon-flat-red-play-button-logo-vector.png

03

Dr. Thomas Wang discusses which patients need the sentinel lymph node biopsy (SLNB)

youtube-icon-flat-red-play-button-logo-vector.png

04

Dr. Dan Coit explains sentinel lymph node biopsy (SLNB), the consultation process for the sentinel lymph node biopsy (SLNB), and the day of the surgery

youtube-icon-flat-red-play-button-logo-vector.png

05

Dr. Dan Coit discusses the complications associated with the sentinel lymph node biopsy 

youtube-icon-flat-red-play-button-logo-vector.png

06

Dr. Dan Coit discusses the controversy associated with the sentinel lymph node biopsy procedure

youtube-icon-flat-red-play-button-logo-vector.png

07

Dr. Richard Carvajal discusses the role of adjuvant treatment for stage IIb/IIc disease

youtube-icon-flat-red-play-button-logo-vector.png

08

Dr. April Salama discusses the role of adjuvant treatment for stage IIb/IIc disease

youtube-icon-flat-red-play-button-logo-vector.png

09

Dr. Paul Chapman discusses the role of adjuvant treatment for stage IIb/IIc disease starting at minute 7:50. Before that Dr. Chapman discusses the role of adjuvant treatment for stage III disease.

bottom of page